StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report released on Wednesday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright lifted their price target on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
View Our Latest Research Report on SenesTech
SenesTech Price Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- How to Invest in Blue Chip Stocks
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- 3 Tickers Leading a Meme Stock Revival
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Canada Bond Market Holiday: How to Invest and Trade
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.